Pediatric cancers are highly enriched with leukemias. We have enrolled >3000 leukemia samples. On the other hand, brain tumors and solid tumors are underrepresented due to lower incidence rate (we currently have ~1500 pediatric brain tumor/solid tumor samples). The addition of 867 brain tumors from CBTN will enhance our power of discovery and also allow us to validate our findings in our existing cohort.
Get the Latest
news, articles, and resources sent to your inbox.